LifeMine Therapeutics announced the addition of two new executives — Martin Stahl as chief scientific officer and Louis Plamondon as EVP and head of chemistry, manufacturing, and controls. “Martin and ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, today ...